Across TCGA pan-cancer cohorts, OR6C70 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR6C70 data layer compared with 2 for mutation status.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher OR6C70 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR6C70 expression acts as an unfavorable survival marker, although some lineages such as SARC and UCEC show a favorable association.
LIHC, KIRC, and UCS are the cancer types where OR6C70 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.